Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Tibotec Virco-Virology presents REALIZE trial results
REALIZE is the final of three clinical trials conducted as part of a global Phase 3 registration program for telaprevir in treatment-naïve and treatment-failure patients with chronic HCV
REALIZE is the final of three clinical trials conducted as part of a global Phase 3 registration program for telaprevir in treatment-naïve and treatment-failure patients with chronic HCV
OMS103HP did not meet the pre-specified endpoints of these studies. No conclusions were made regarding the drug-effect due to confounding factors in the studies. Omeros chairman and chief
The randomised, double-blind, placebo-controlled, parallel-group, multi-centre Phase III study will evaluate the safety and efficacy dexpramipexole in people with familial or sporadic ALS. The study will enroll approximately
The drug has been approved as a treatment for anemia in adults and children six years of age or older, undergoing chronic hemodialysis who are receiving supplemental epoetin
The designer is expected to help GSK to design its studies that meet key objectives and collect necessary data in a streamlined and efficient manner. Medidata claims that
Cloderm (clocortolone pivalate) cream, 0.1% is a topical mid potent steroid product indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. As per the
The new patent will provide Apricus Bio protection for Vitaros until 2026. The MPO has issued a ‘notice of allowance for the patent entitled, ‘Topical Stabilized Prostaglandin E
Laninamivir is an influenza antiviral, known as a neuraminidase inhibitor (LANI) and a treatment for influenza. The contract is designed to provide US based manufacturing and clinical data
Originally, the FDA has requested a permanent injunction against Deltex and its president Kabir Ahmed and vice president Mohidur Khan, as the company allegedly failed to obtain approval
PCMT is available through the company’s CLIA (Clinical Laboratory Improvement Amendments) lab in Aurora, Colorado. Utilizing its cancerization field effect to identify molecular changes and enable detection of